Tagged with

One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What were the strategic motivations for establishing a presence in Belgium? Since NNE Pharmaplan concentrates on providing services based on our pharmaceutical and life sciences heritage, which we have…

Grünenthal GmbH You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the position and how have they panned out so far? I wanted to make a change — a change for patients; a change for those…

Takeda Pharma GmbH Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of roughly €80 million, according to IMS figures. In primary care markets we focus on core therapeutic areas such as cardiovascular…

Aldimed As a means of introduction, could you please describe the origins of ALDIMED, how it started, its development the past couple of years and where it stands today? ALDIMED represents the medical technology industry in Latin America; this is a Colombian initiative and one of its founders. The Executive Board…

AbbVie Austria You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a global biopharmaceutical company, which as of January 2nd is being traded on the New York Stock Exchange as an independent…

Belgium Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout the years? Tom Heyman (TH): Janssen Pharmaceutica is all about innovation—developing, producing and providing innovative healthcare solutions for patients. When…

Janssen Pharmaceutica Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout the years? Tom Heyman: Janssen Pharmaceutica is all about innovation—developing, producing and providing innovative healthcare solutions for patients. When I…

Can you please introduce us to Dalkia? Pat Gilroy: Dalkia is a multinational company that operates in over 40 countries throughout the world and turns over 8Bn EUR annually. We are the energy management and utilities services subsidiary of Veolia Environment and Électricité de France. Dalkia formed a subsidiary in…

Rottapharm Ireland Mr. Garrahy, can you please begin by introducing yourself and this production facility to our readers? I joined Rottapharm in 1998, when the organization decided to establish its Dublin production facility. Prior to that, I was a plant manager for Warner Lambert in Cork. When I took on this role,…

Kedrion International GmbH Prior to joining Kedrion you worked for CSL Behring for a number of years. What opportunities did you see for yourself in moving from there to Kedrion? The biggest opportunity was to join a younger, smaller company that was at an earlier stage of development compared to a larger, more…

Pharmachemical Ireland Mr. Moran, can you please begin with a brief introduction to Pharmachemical Ireland, its mission, and how it works to achieve its goals?   Pharmachemical Ireland (PCI) is an industry association representing the pharmaceutical, chemical, and biopharmaceutical manufacturing sectors in Ireland. Our raison d’être is to ensure that the regulatory…

We’re meeting you just after a conference where you were a keynote speaker. Could you share with us some of your insights from the day’s events? The conference was a forum for graduate students interested in entrepreneurship. The government, now, is trying to encourage people to do business. China, with…